<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3006210835
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FAMODAR
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FAMOTIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        25.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Famodar<sup>&reg; </sup></strong>belongs to a group of medicines called histamine (H2) antagonists or anti-ulcer medicines. These anti-ulcer medicines control the levels of acid in the stomach. <strong>Famodar<sup>&reg; </sup></strong>can lower the amount of acid you produce in your stomach.</p><p>&nbsp;</p><p><strong>Famodar<sup>&reg; </sup></strong>can be used for the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To help treat non-cancerous stomach ulcers and ulcers in the first part of your intestine (duodenal ulcers)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To help prevent the return of ulcers in the first part of the intestine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To help treat Zollinger-Ellison syndrome (with a condition caused by too much stomach acid)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To help treat acid reflux (burning pain caused by stomach acid escaping back up the food pipe) and the symptoms of an inflamed food pipe (oesophagitis)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take </strong><strong>Famodar<sup>&reg; </sup></strong><strong>if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are allergic to famotidine or any of the ingredients of this medicine (listed in section 6) or to any other medicines called H2 antagonists</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking <strong>Famodar<sup>&reg; </sup></strong>if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have kidney problems</p><p>&nbsp;</p><p><strong>Famodar<sup>&reg; </sup></strong>may hide the symptoms of other diseases. Your doctor may carry out tests to diagnose your condition and/or exclude other diseases before you start taking <strong>Famodar<sup>&reg;</sup></strong>.</p><p><strong>&nbsp;</strong></p><p><strong>During treatment</strong></p><p>If you take a high dose for a long time your doctor may carry out blood tests to check your blood cells and liver function.</p><p><strong>&nbsp;</strong></p><p><strong>Children and adolescents</strong></p><p><strong>Famodar<sup>&reg; </sup></strong>should not be given to children or adolescents</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and </strong><strong>Famodar<sup>&reg;</sup></strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, especially any of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itraconazole or ketoconazole, medicines used to treat fungal infections. Take ketoconazole 2 hours before your famotidine dose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; probenecid, a medicine used to treat gout</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antacids. Take your famotidine dose one to two hours before an antacid</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sucralfate, a medicine used for stomach ulcers. Do not take sucralfate within two hours of your famotidine dose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Famodar<sup>&reg; </sup></strong>may decrease the effect of posaconazole oral suspension (a drinkable medicine used to prevent and treat some fungal infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Famodar<sup>&reg; </sup></strong>may decrease the effect of dasatinib, erlotinib, gefitinib, pazopanib (medicines used to treat cancer).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; atazanavir, used in the treatment of HIV</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calcium carbonate, when used as a medicine for high blood phosphate levels (hyperphosphataemia) in patients on dialysis</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p><u>Pregnancy</u></p><p>If you are pregnant, think you may be pregnant or are planning to have a baby, talk to your doctor first before taking this medicine. If you do get pregnant while taking <strong>Famodar<sup>&reg; </sup></strong>you must tell the doctor straightaway.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Famotidine passes into breast milk. If you are breast-feeding or planning to breast feed, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Do not drive or operate machines if you feel dizzy or get a headache while taking <strong>Famodar<sup>&reg;</sup></strong>.</p><p><strong>&nbsp;</strong></p><p><strong>Important information about some of the ingredients of Famodar</strong><sup>&reg;</sup></p><p><strong>Famodar</strong><sup>&Ograve;</sup> 20 mg and 40 mg tablets contain sunset yellow (E110), in addition to red carmoisine (E122) in <strong>Famodar</strong><sup>&Ograve;</sup> 40 tablets. These ingredients<strong> </strong>may cause allergic reaction.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Famodar</strong><sup>&reg; </sup>Tablets can be taken before or after food.</p><p><strong>&nbsp;</strong></p><p><strong>Use in adults </strong>(including the elderly)</p><p><strong>Non-cancerous stomach or intestinal ulcers </strong>- The recommended dose is 40 mg of famotidine taken at night. In some cases treatment may last for up to 8 weeks.</p><p><strong>To prevent intestinal ulcers from returning </strong>- The recommended dose is 20 mg of famotidine at bedtime.</p><p><strong>To treat Zollinger-Ellison syndrome </strong>- The recommended starting dose is 20 mg of famotidine every 6 hours. Your doctor may need to increase this dose further depending how well the ulcers are healing. If you have already been taking a similar medicine or your symptoms are severe, your doctor may start you on a higher dose of famotidine.</p><p><strong>To treat mild symptoms of oesophagitis </strong>(inflammation of the food pipe)<strong>, due to acid reflux </strong>- The recommended dose is 20 mg of famotidine twice daily.</p><p>Treatment usually lasts for 6 weeks, but if necessary, for 12 weeks.</p><p><strong>To treat more severe symptoms of oesophagitis </strong>(inflammation of the food pipe) &ndash; The recommended dose is 40 mg of famotidine twice daily. Treatment usually lasts for 6 weeks, but if necessary, for 12 weeks.<strong>&nbsp;</strong></p><p><strong>Use in people with kidney problems</strong></p><p>If you suffer from kidney problems, your doctor may give you a lower dose of <strong>Famodar</strong><sup>&reg;</sup>. &nbsp;If you are having dialysis, your doctor may advise you to take a 20 mg tablet after dialysis.</p><p><strong>&nbsp;</strong></p><p><strong>Use in children and adolescents&nbsp;</strong></p><p><strong>Famodar</strong><sup>&reg; </sup>should not be given to children or adolescents.<strong>&nbsp;</strong></p><p><strong>If you take more </strong><strong>Famodar</strong><sup>&reg; </sup><strong>than you should</strong></p><p>If you take too much of your medicine contact your doctor or go straight to the nearest hospital emergency department immediately.</p><p><strong>If you forget to take </strong><strong>Famodar</strong><sup>&reg;</sup></p><p>If you forget to take your dose of <strong>Famodar</strong><sup>&reg;</sup>, unless it is almost time for your next dose, take it as soon as you remember. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking </strong><strong>Famodar</strong><sup>&reg;</sup></p><p>If you have had stomach or intestinal ulcers for a long time you should not stop taking <strong>Famodar</strong><sup>&reg; </sup>if you feel better, without asking for advice from your doctor first.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Stop taking </strong><strong>Famodar</strong><sup>&reg; </sup><strong>and contact your doctor or go to your nearest hospital emergency department immediately if you notice any of the following:</strong></p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a serious allergic reactions including rash, itching or hives, shortness of breath, wheezing or trouble breathing, or swelling of the face, hands, feet, mouth, throat or eyes.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the skin or whites of the eyes, dark urine, pale stools, persistent lack of appetite or abdominal pain which may be signs of serious liver problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a severe blistering rash with bleeding in the lips, eyes, mouth, nose and genitals or severe skin reactions which starts with painful red areas or severe skin reactions which starts with painful red areas, then large blisters and ends with peeling of the surface layers of the skin. You may have Stevens-Johnson syndrome or condition known as Toxic Epidermal Necrolysis (TEN), which may be life-threatening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a burning sensation in the chest, shortness of breath and a persistent cough (these may be signs you have a lung infection (pneumonia) which may be severe). You may also get tired, have blue lips or fingertips (cyanosis) or lose weight.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits or seizures where you may lose consciousness, cry out or have jerky movements, feel a warning (aura) beforehand and afterwards may be confused, tired or have a severe headache. If you have kidney problems you are more at risk of seizures.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to the electrical activity of the heart seen on an EEG. You may feel light headed. Patients given this type of medicine by injection, have experienced some changes in heart rhythm or an irregular heart beat</p><p><strong>&nbsp;</strong></p><p><strong>Stop taking </strong><strong>Famodar</strong><sup>&reg; </sup><strong>and contact your doctor as soon as possible if you notice any of the following:</strong></p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an increase in the number of infections, you may get such as fever, severe chills, sore throat or mouth ulcers (these may be the signs that you have a low number of white blood cells in the body)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low numbers of other blood cells, causing tiredness, shortness of breath, coldness in your hands and feet and pale skin (low number of red blood cells), unusual bruising or bleeding more easily than normal, difficulty in healing after a cut (low number of platelets)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression, confusion, feeling disorientated, anxious or agitated, or seeing, hearing or feeling things that are not real (hallucinations)</p><p>&nbsp;</p><p>Other side effects</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling unusually tired</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling or being sick</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in taste</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wind</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling bloated</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy skin or rash</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an increase in liver enzymes in the blood, seen in a blood test</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; enlarged breasts in men. However it is not certain this effect is caused by famotidine.<strong>&nbsp;</strong></p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty getting or maintaining an erection or a reduction in your sex drive</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tingling or numbness in the fingers and toes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty sleeping</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drowsiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest tightness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a change in blood liver enzymes seen in a blood test</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain or muscle cramps</p><p><strong>Unknown </strong>(frequency cannot be estimated from the available data<strong>)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Cardiovascular disorders</strong><strong>: </strong>Arrhythmia, QT prolongation</p><p>&nbsp;</p><p><strong>Reporting of side effects </strong></p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use <strong>Famodar<sup>&reg;</sup></strong> after the expiry date, which is stated on the carton. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Protect from light. Store in a dry place. Do not store above 30&deg;C.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of any medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance in <strong>Famodar<sup>&reg;</sup> </strong>is famotidine. Each film coated tablet contains 20 or 40mg famotidine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>The other ingredients are:</strong> microcrystalline cellulose, pregelatinized starch, magnesium stearate, talc, hypromellose, titanium dioxide, macrogol, sunset yellow (E110). <strong>Famodar</strong><sup>&reg;</sup> <strong>40mg</strong> tablets also contain red carmiosine (E122) and indigo carmine (E132).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Famodar® 20mg tablets are yellow orange round normal biconvex film coated tablets, coded (FAM 20) on one side, plain on the other side. 

Famodar® 40mg tablets are brick-colored round normal biconvex film coated tablets coded (FAM 40) on one side, plain on the other side. 

Famodar® tablets are packed in Aluminum – PVC/PVDC blisters of 10. Famodar® 20 mg film coated tablets are available in packs of 20 (two blisters), 30 (three blisters) and 500 (50 blisters). Famodar® 40 mg film coated tablets are available in packs of 10 (one blister) and 500 (50 blisters).

Not all pack sizes may be marketed. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co Ltd</p><p>Prince Hashem Bin Al-Hussein Street.</p><p>Na&rsquo;ur &ndash; Amman &ndash; Jordan.</p><p>Tel. (+962 6) 22 22 200</p><p>Fax. (+962 6) 57 27 776</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effects: </strong></p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jordan</strong></p><p>o&nbsp;&nbsp;&nbsp;&nbsp; Jordan Food and Drug Administration</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phone: +962 6 5632000</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.jfda.jo</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reporting link&nbsp; https://primaryreporting.who-umc.org/jo</p><p>Email: jpc@jfda.jo&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United Arab Emirates</strong></p><p>&nbsp;</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacovigilance and Medical Device Section</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug Department</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UAE Ministry of health &amp; Prevention</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hotline: 80011111</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: pv@mohap.gov.ae</p><p>P.O. Box: 1853 Dubai UAE</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudan</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Medicines and Poisons Board (NMPB)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Fax: + 249 183522263</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; E-mail: info@nmpb.gov.sd</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Website : www.nmpb.gov.sd</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other countries</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp; -Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي <strong>فامودار</strong> إلى مجموعة من الأدوية تدعى حاصرات مستقبل الهستامين 2 أو الأدوية المضادة للقرحات. تعمل هذه الأدوية المضادة للقرحات على السيطرة على مستويات الحمض في المعدة. يقلل <strong>فامودار</strong> من كمية الحمض الذي يتم إنتاجه في معدتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن استخدام <strong>فامودار</strong> لعلاج الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المساعدة في علاج القرحات غير المسرطنة في المعدة والجزء الأول من الأمعاء (قرحات الإثني عشر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; منع حدوث قرحات من جديد في الجزء الأول من الأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج متلازمة زولنجير إليسون (بسبب فرط إنتاج الحمض في المعدة)</p><p dir="RTL">علاج ارتداد المعدة (الشعور بحرقة مؤلمة بسبب ارتجاع حمض المعدة في أنبوب الطعام) وأعراض التهاب أنبوب الطعام (التهاب المريء)&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع</strong><strong> </strong><strong>إستعمال </strong><strong>فامودار&nbsp; </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك حساسية تجاه فاموتيدين أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم 6) أو تجاه أي من أدوية حاصرات هستامين 2 الأخرى</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المحاذير والاحتياطات </strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول<strong> فامودار </strong>في حال: &nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من مشاكل في الكلى</p><p dir="RTL">يمكن أن يسبب استخدام <strong>فامودار</strong> إختفاء أعراض مرتبطة بأمراض أخرى. من الممكن أن يقوم طبيبك بإجراء فحوصات للكشف عن حالتك المرضية و/أو استبعاد الأمراض الأخرى قبل البدء باستخدام <strong>فامودار</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أثناء العلاج</strong></p><p dir="RTL">في حال كنت تتناول جرعة مرتفعة لفترة زمنية طويلة فقد يطلب طبيبك إجراء فحوصات للدم للتحقق من خلايا الدم الحمراء ووظيفة الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال واليافعون </strong></p><p dir="RTL">لا ينبغي استخدام <strong>فامودار</strong> في الأطفال واليافعين</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية من تناول فامودار مع أي أدوية أخرى أو أعشاب أو مكملات</strong></p><p dir="RTL">أبلغ طبيبك أو الصيدلي في حال كنت تتناول، أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، وخصوصًا أي من الأدوية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيتراكونازول أو كيتوكونازول، أدوية تستخدم لعلاج العدوى الفطرية. قم بتناول كيتوكونازول قبل ساعتين من تناول جرعة فاموتيدين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بروبنيسيد، دواء يستخدم لعلاج النقرس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الحموضة. ينبغي تناول فاموتيدين قبل ساعة إلى ساعتين من تناول مضادات الحموضة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكرالفيت، دواء يستخدم لعلاج قرحات المعدة. تجنب تناول سكرالفيت خلال ساعتين من تناول جرعة فاموتيدين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن يقلل <strong>فامودار</strong> من مفعول المعلق الفموي بوساكونازول (وهو دواء قابل للشرب يستخدم لمنع وعلاج العدوى الفطرية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن يقلل <strong>فامودار</strong> من مفعول داساتينيب، إيرولتينيب، جيفيتينيب، بازوبانيب (وهي أدوية تستخدم لعلاج السرطان). [RTA1]&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أتازانافير، يستخدم لعلاج عدوى فيروس نقص المناعة المكتسبة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كربونات الكالسيوم، وذلك عند استخدامها لعلاج مستويات الفوسفات المرتفعة في الدم (فرط فوسفات الدم) في المرضى الذي يخضعون للديلزة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة </strong></p><p dir="RTL"><u>الحمل</u></p><p dir="RTL">إذا كنتِ حاملًا، تعتقدين بأنك حامل أو تخططين للحمل، استشيري الطبيب أولاً قبل تناول هذا الدواء. إذا أصبحت حاملاً أثناء تناول <strong>فامودار</strong> فيجب عليكِ إخبار الطبيب على الفور.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><u>الرضاعة </u></p><p dir="RTL">يعبر فاموتيدين إلى حليب الأم. إذا كنت مرضعًا أو تخططين للرضاعة الطبيعية فإنه ينبغي عليكِ استشارة طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير فامودار على القيادة واستخدام الآلات</strong></p><p dir="RTL">لا تقم بالقيادة أو تشغيل الآلات إذا شعرت بالدوخة أو أصبت بصداع أثناء تناول <strong>فامودار</strong>. &nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات فامودار</strong></p><p dir="RTL">تحتوي أقراص <strong>فامودار</strong> 20 ملغم و40 ملغم على لون أصفر ((E110، بالإضافة لون أحمر (E122) في أقراص <strong>فامودار</strong> 40 ملغم. قد تسبب هذه المكونات تفاعلات حساسية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائمًا كما أخبرك طبيبك أو الصيدلي. تحقق من طبيبك أو الصيدلي اذا لم تكن متأكدًا.&nbsp;</p><p dir="RTL">يمكن تناول أقراص <strong>فامودار</strong> قبل أو بعد الطعام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام في البالغين</strong> (بما فيهم كبار السن)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القرحات غير المسرطنة في المعدة أو الأمعاء </strong>&ndash; الجرعة الموصى بها من فاموتيدين هي 40 ملغم تؤخذ مساءً. من الممكن أن يستمر العلاج لمدة 8 أسابيع كحد أقصى.<strong> </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لمنع تكرار الإصابة بالقرحات المعوية</strong> &ndash; الجرعة الموصى بها هي 20 ملغم من فاموتيدين وقت النوم.<strong> </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لعلاج متلازمة زولينجر إليسون - </strong>الجرعة الموصى بها هي 20 ملغم من فاموتيدين كل 6 ساعات. قد يلزم الطبيب زيادة الجرعة فيما بعد بناءًا على مدى درجة التئام القرحات. إذا كنت تتناول في الأصل دواءً مشابهاً أو كانت الأعراض لديك شديدة، من الممكن أن يبدأ معك الطبيب بجرعة مرتفعه من فاموتيدين.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لعلاج أعراض التهاب المريء الخفيفة </strong>(التهاب قناة الطعام)<strong>، بسبب ارتجاع الحمض - </strong>الجرعة الموصى بها هي 20 ملغم من فاموتيدين مرتين يومياً<strong>. </strong></p><p dir="RTL">يستمر العلاج عادة لمدة 6 أسابيع، لكن يمكن تمديده إلى 12 أسبوع عند الضرورة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج الأعراض الأكثر شدة لالتهاب المريء</strong> (التهاب قناة الطعام) - الجرعة الموصى بها هي 40 ملغم من فاموتيدين مرّتان يومياً. يستمر العلاج عادة لمدة 6 أسابيع، لكن يمكن تمديده إلى 12 أسبوع عند الضرورة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المرضى المصابون بمشاكل في الكلى </strong></p><p dir="RTL">في حال كنت تعاني من مشاكل في الكلى، فمن المرجح أن يصف لك الطبيب جرعة أقل من <strong>فامودار</strong>. في حال كنت تخضع للديلزة، قد ينصحك الطبيب بأخذ قرص 20 ملغم بعد إنهاء الديلزة.&nbsp; &nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام في الأطفال واليافعين </strong></p><p dir="RTL">يمنع إعطاء <strong>فامودار</strong> للأطفال أو اليافعين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت فامودار أكثر من اللازم </strong></p><p dir="RTL">إذا تناولت الدواء بأكثر من اللازم تواصل مع الطبيب أو توجه إلى أقرب قسم طوارئ على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت أن تتناول فامودار</strong><strong> </strong></p><p dir="RTL">إذا نسيت تناول الجرعة من <strong>فامودار</strong>، تناول الجرعة فور تذكرك، إلا إذا حان وقت الجرعة التالية. لا تأخذ جرعة مضاعفة للتعويض عن الجرعة الفائتة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول فامودار</strong></p><p dir="RTL">إذا كنت تعاني من قرحات معدية أو معوية منذ فترة زمنية طويلة فإنه لا ينبغي بك التوقف عن أخذ <strong>فامودار</strong> بمجرد أنك شعرت بتحسن، دون استشارة الطبيب أولاً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام الدواء، اسأل الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال في كل الأدوية، قد يسبب هذا الدواء أعراضاً جانبية، بالرغم من أنها قد لا تحدث عند جميع المرضى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>توقف عن تناول فامودار وتواصل مع طبيبك أو توجه إلى أقرب قسم طوارىء على الفور إذا لاحظت ظهور أي من التالي:</strong></p><p dir="RTL"><strong>نادرة جداً </strong>(قد تؤثر على شخص واحد من كل 10000 شخص كحد أقصى)<strong> </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات تحسسية خطيرة تشمل طفح جلدي، حكة أو شرى، قصر التنفس، أزيز أو مشاكل في التنفس، أو تورم الوجه، اليدين، القدمين، الفم، الحلق أو العينين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو بياض العينين، بول غامق، براز بلون شاحب، فقدان للشهية مستمر أو ألم في البطن والذي من الممكن أن يكون علامة على مشاكل في الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح متقرح بشدة مصحوب بنزيف في الشفاه، العينين، الفم، الأنف والأعضاء التناسلية أو تفاعلات جلدية شديدة والذي يبدأ بمناطق حمراء من الجلد وتسبب ألمًا، وثم تتطور إلى تقرحات كبيرة وتنتهي بتقشير في الطبقات الخارجية للجلد. من الممكن أن تصاب بمتلازمة ستيفنز-جونسون أو حالة تدعى بإنحلال البشرة السمي، بحيث تكون هذه الحالات مهددة للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بحرقة في الصدر، قصر في التنفس وسعال مستمر لفترة طويلة (قد تدل هذه العلامات على الإصابة بعدوى رئوية (التهاب رئوي) والذي قد يكون شديدًا). وقد تشعر أيضاً بتعب، تغير لون الشفاه إلى الأزرق (زرقة) أو نقصان الوزن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلاجات أو تشنجات بحيث قد تفقد الوعي، الهتاف أو القيام بحركات متقلبة، الشعور بنذير مسبق (أورة) ثم يليه الشعور بارتباك، تعب أو صداع شديد. إذا كنت تعاني من مشاكل في الكلى فقد تكون أكثر عرضة للإصابة بتشنجات.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تغيرات في النشاط الكهربائي للقلب والذي يتم الكشف عنه من خلال تخطيط القلب الكهربائي. قد تشعر بخفة في الرأس. قد يتعرض المرضى الذين يتلقون هذا الدواء عن طريق الحقن إلى بعض التغيرات في القلب والنظم القلبية أو اضطراب ضربات القلب<strong> </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>توقف عن تناول فامودار وتواصل مع طبيبك في أقرب وقت ممكن إذا لاحظت حدوث أي من التالي: </strong></p><p dir="RTL"><strong>نادرة جداً </strong>(قد تؤثر على شخص واحد من كل 10000 شخص كحد أقصى)<strong> </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في عدد الإصابة بالعدوى، قد تصاب بالحمى، قشعريرة شديدة، التهاب الحلق أو تقرحات في الفم (قد تدل هذه العلامات على انخفاض عدد خلايا الدم البيضاء في الجسم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تعداد خلايا الدم الأخرى، مما يسبب تعب، قصر في التنفس، برودة في اليدين والقدمين وشحوب في الجلد (انخفاض عدد خلايا الدم الحمراء)، ظهور كدمات بشكل غير إعتيادي أو تصبح أكثر قابلية للنزيف بشكل أسهل من الطبيعي، صعوبة في التئام الجرح (انخفاض عدد الصفائح)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكتئاب، ارتباك، الشعور بتوهان، قلق أو اهتياج، أو رؤية، أو سماع أو الشعور بأشياء غير حقيقية (هلوسة)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">الأعراض الجانبية الأخرى</p><p dir="RTL"><strong>شائعة </strong>(قد تؤثر على شخص واحد من كل 10 أشخاص كحد أقصى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إمساك</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إسهال</p><p dir="RTL"><strong>غير شائعة</strong> (قد تؤثر على شخص واحد من كل 100 شخص كحد أقصى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف في الفم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتعب غير اعتيادي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غثيان أو تقيؤ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في حاسة التذوق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غازات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بانتفاخ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة في الجلد أو طفح</p><p dir="RTL"><strong>نادرة</strong> (قد تؤثر على شخص واحد من كل 1000 شخص كحد أقصى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في مستويات إنزيمات الكبد في الدم تظهر في الفحوصات الدموية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم الأثداء لدى الرجال. إلا أنه غير مؤكد ما إذا كان ذلك يحدث بسبب فاموتيدين.</p><p dir="RTL"><strong>نادرة جداً</strong> (قد تؤثر على شخص واحد من كل 10000 شخص كحد أقصى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على القذف أو انخفاض الرغبة الجنسية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز أو تنمل في أصابع الأيدي والأقدام</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في النوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير في مستوى إنزيمات الكبد تظهر في فحوصات الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المفاصل وتشنج العضلات</p><p dir="RTL"><strong>غير معروفة </strong>(لا يمكن تقدير تكرارها من البيانات المتاحة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اضطرابات القلب والأوعية الدموية</strong><strong>: </strong>اضطراب نظم القلب، استطالة فترة كيو تي</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا كان لديك أعراض جانبية أو لاحظت أعراضًا جانبية غير مذكورة في هذه النشرة، فضلاً أبلغ الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدًا عن متناول أيدي الأطفال ونظرهم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم <strong>فامودار</strong> بعد تاريخ الانتهاء المذكور على العبوة الخارجية. يدل تاريخ الانتهاء على آخر يوم في الشهر المذكور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدًا عن الضوء في مكان جاف. يحفظ على درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الدواء عن طريق رميه في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الدواء الذي لم تعد بحاجته. تساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة في<strong> فامودار </strong>هي فاموتيدين. يحتوي كل قرص مغلف على 20 أو 40 ملغم من فاموتيدين.<strong> </strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>المكونات الأخرى هي:</strong> سيليلوز دقيق البلورية، نشا مهيلم، ستيارات المغنيسيوم، تالك، هيبروميلوز، ثاني أكسيد التيتانيوم، ماكروغول، لون أصفر((E110. بالاضافة الى ما سبق تحتوي أقراص <strong>فامودار40 ملغم </strong>أيضا<strong> </strong>على لون أحمر (E122) و لون أزرق (E132).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما</strong><strong> </strong><strong>هو</strong><strong> </strong><strong>الشكل</strong><strong> </strong><strong>الصيدلاني</strong><strong> </strong><strong>لفامودار وعلى ماذا تحتوي العبوة</strong></p><p dir="RTL">أقراص<strong> فامودار</strong> 20 ملغم هي أقراص مغلفة دائرية محدبة الوجهين لونها أصفر إلى برتقالي، مرمزة&nbsp; بالرمز(FAM20) على جهة واحدة، ملساء على الجهة الاخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أقراص<strong> فامودار</strong> 40 ملغم هي أقراص مغلفة دائرية محدبة الوجهين لونها قرميدي، مرمزة بالرمز (FAM40) على جهة واحدة، ملساء على الجهة الأخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تغلف أقراص <strong>فامودار</strong> في أشرطة من الألمنيوم والبلاستيك يحتوي كل منها على 10 أقراص. تتوفر أقراص <strong>فامودار</strong> 20 ملغم المغلفة في عبوات تحتوي 20 قرص (شريطين)، 30 قرص (ثلاث أشرطة) و500 قرص (50 شريط). &nbsp;وتتوفر أقراص <strong>فامودار</strong> 40 ملغم المغلفة في عبوات تحتوي 10 أقراص (شريط واحد) و500 قرص (50 شريط).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة دار الدواء للتنمية والاستثمار المساهمة المحدودة</p><p dir="RTL">شارع الأمير هاشم بن الحسين</p><p dir="RTL">ناعور- عمان - الأردن</p><p dir="RTL">هاتف. 200 22 22 (6 962 +)</p><p dir="RTL">فاكس.776 27 57 (6 962 +)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية :</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأردن</strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp; المؤسسة العامة للغذاء والدواء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الرقم: +962 6 5632000</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الموقع الالكتروني: www.jfda.jo</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; رابط التبليغ: https://primaryreporting.who-umc.org/jo</p><p>البريد الالكتروني: jpc@jfda.jo</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربية السعودية</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><ul><li dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرقم الموحد 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الالكتروني: &nbsp;https://ade.sfda.gov.sa</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمارات العربية المتحدة</strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قسم اليقظة الدوائية والوسائل الطبية</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إدارة الدواء</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وزارة الصحة ووقاية المجتمع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخط الساخن: ٨٠٠١١١١١</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ايميل: pv@mohap.gov.ae</p><p>صندوق بريد: ١٨٥٣ دبي الامارات العربية المتحدة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السودان</strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المجلس القومي للأدوية والسموم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: 522263 183 (249+)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: info@nmpb.gov.sd</p><p>الموقع الإلكتروني: www.nmpb.gov.sd</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدول الأخرى</strong></p><p dir="RTL">&nbsp;-الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03/2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Famodar® 40 mg film coated tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Famodar® 40 mg film coated tablets: Each film coated tablet contains 40 mg Famotidine.
For excipients, see 6.1 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film coated tablets 
Famodar® 40 mg is brick-colored round normal biconvex film coated tablet coded (FAM 40) on one side, plain on the other side. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Duodenal and benign gastric ulcers which have been confirmed by radiological or endoscopic examination.</p><p dir="ltr">Zollinger-Ellison syndrome</p><p dir="ltr">Reflux oesophagitis confirmed by endoscopy, including curative treatment of erosion or ulcer associated with reflux oesophagitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p><em>Duodenal ulcer.</em></p><p>Initiation of treatment: The recommended dose is 40 mg of famotidine per day at bedtime. The treatment should be continued for 4-8 weeks, but it may be discontinued even earlier if it is found by endoscopic examination that the ulcer has healed. In most cases the ulcer will heal with this treatment within four weeks. Treatment should be continued for another four weeks in patients whose ulcer has not healed completely within four weeks.</p><p>Maintenance treatment: In prophylactic treatment of recurrent ulcer it is recommended that famotidine therapy be continued with a dose of 20 mg per day at bedtime.</p><p><em>Non-malignant gastric ulcer.</em></p><p>The recommended dose is 40 mg per day at bedtime. The treatment is continued for 4-8 weeks, but a shorter course of treatment is adequate if an endoscopic examination shows that the ulcer is healed.</p><p><em>Zollinger-Ellison syndrome.</em></p><p>If the patient has not previously received drugs to reduce the secretion of acid, the treatment is introduced by giving 20 mg of famotidine every 6 hours. The dosage should be adjusted according to the patient&#39;s needs and it should be continued as long as it is clinically indicated. Daily doses up to 800 mg have been administered without any significant undesirable effects or tachyphylaxis. If the patient has received another H<sub>2</sub>&nbsp;blocking agent, famotidine therapy can be introduced in a larger dose than otherwise recommended. The size of the initial dose is dependent on the severity of the condition and on the size of doses of H<sub>2</sub>&nbsp;blocking agents received until that time.</p><p><em>Reflux oesophagitis.</em></p><p>The recommended dose for the relief of symptoms of reflux oesophagitis is 20 mg of famotidine twice daily. Doses should be continued for as long as indicated.</p><p>The recommended dose for the treatment of erosion or ulcer associated with reflux oesophagitis is 40 mg of famotidine twice daily. The recommended treatment length is 6-8 weeks.</p><p>Maintenance treatment:</p><p>If long-term management of reflux oesophagitis by famotidine is considered relevant, the recommended dose is 20 mg twice daily.</p><p>At present, this prophylactic treatment is not recommended to be extended beyond six months.</p><p><em>Renal impairment:</em></p><p>Famotidine is primarily eliminated via the kidneys. For patients with impaired renal function in whom creatinine clearance is less than 10ml/min, the daily dose of famotidine should be reduced by 50%. Caution is advised in patients with renal impairment. Dialysis patients should also take doses that are reduced by 50%. Famotidine tablets should be administered at the end of dialysis or later since some of the active ingredient is removed by dialysis.</p><p><em>Hepatic impairment</em></p><p>In patients with cirrhosis of the liver, the plasma concentration and elimination of famotidine in the urine were the same as that of healthy volunteers. Reduction of the dose is therefore not necessary in these patients.</p><p><em>Elderly</em></p><p>When famotidine was administered to elderly patients in clinical studies the undesirable effects associated with the drug were not found to increase nor were they found to be different from those exhibited in younger patients. Adjustment of dose based on age is therefore not necessary.</p><p><em>Paediatric population:&nbsp;</em>Not recommended.</p><p><strong><u>Method of administration</u></strong></p><p>The tablets should be taken with some liquid. They can be divided, but they must not be crushed or chewed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Cross sensitivity in this class of compounds has been observed. Therefore, Famotidine should not be administered to patients with a history of hypersensitivity to other H2-receptor antagonists.
For administration to breast-feeding women: see section 4.6
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Since cross sensitivity has been observed among H<sub>2</sub>-receptor antagonists, famotidine should not be administered to patients with a history of hypersensitivity to other drugs in this class.</p><p><em>Gastric neoplasm</em></p><p>Before starting treatment of gastric ulcer with famotidine, the possibility of malignant gastric tumour should be excluded. The symptomatic response of a gastric ulcer to famotidine therapy does not exclude the possible existence of a malignant tumour.</p><p>Do not administer famotidine tablets in cases of minor gastro-intestinal complaints.</p><p>In patients with duodenal ulcers and benign gastric ulcers the H. Pylori status should be determined. Wherever possible, patients with H. Pylori should undergo eradication therapy to eliminate the bacteria.</p><p><em>Renal insufficiency.</em></p><p>Since famotidine is secreted mainly via the kidneys, caution should be exercised when treating patients with renal insufficiency. A reduction in the daily dose should be considered if creatinine clearance falls below 10 ml/min (see section 4.2 Posology and Method of administration).</p><p><em><u>Paediatric population</u></em></p><p>In the children are not established safety and efficacy.</p><p><em><u>Use in the elderly</u></em></p><p>When famotidine was administered to elderly patients in clinical trials, no increase in the incidence or change in the type of drug-related side effects was observed. No dosage adjustment is required based on age alone.</p><p><em><u>General</u></em></p><p>In case of long-term treatment with high dosage, monitoring of blood count and liver function is recommended.</p><p>In case of long-standing ulcer disease, abrupt withdrawal after symptom relief should be avoided.</p><p dir="ltr">Famodar<sup>&Ograve;</sup> 40 mg tablets contain sunset yellow (E110) and red carmoisine (E122) which<strong> </strong>may cause allergic reaction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No drug interactions of clinical importance have been identified.</p><p>During concomitant use of drugs where the absorption of the drug is affected by the amount of gastric juice, a possible effect on the absorption should be taken into consideration. The absorption of ketoconazole and itraconazole could be reduced. Ketoconazole should be given two hours before famotidine administration.</p><p>Probenecid inhibits renal tubular secretion of famotidine, and has been shown to cause a 50% increase in plasma levels of famotidine. Therefore, concomitant use of probenecid and famotidine should be avoided.</p><p>Concomitant use of famotidine and antacids could reduce the famotidine uptake and cause lower plasma levels of famotidine. Therefore, famotidine should be administered 1-2 hours before antacids.</p><p>Concomitant use of sucralfate inhibits absorption of famotidine. Therefore, sucralfate should not be administered within 2 hours after famotidine.</p><p>Co-administration of posaconazole oral-suspension with famotidine should be avoided if possible, since famotidine may reduce the absorption of posaconazole oral-suspension during concomitant use.</p><p>Co&ndash;administration of famotidine with the tyrosine kinase inhibitors (TKIs) dasatinib, erlotinib, gefitinib, pazopanib may decrease plasma concentrations of TKIs resulting in lower efficacy, therefore co-administration of famotidine with these TKIs is not recommended. For further specific recommendations please refer to the product information of individual TKI medicinal products.</p><p>Famotidine does not interact with the cytochrome P450-linked drug metabolizing enzyme system. Compounds metabolized by this system which have been tested in man have included warfarin, theophylline, phenytoin, diazepam, propranolol, aminopyrine and antipyrine. Indocyanine green as an index of hepatic blood flow and/or hepatic drug extraction has been tested and no significant effects have been found.</p><p>Studies in patients stabilized on phenprocoumon therapy have shown no pharmacokinetic interaction with famotidine and no effect on the pharmacokinetic or anticoagulant activity of phenprocoumon.</p><p>In addition, studies with famotidine have shown no augmentation of expected blood alcohol levels resulting from alcohol ingestion.</p><p>Alterations of gastric pH may affect the bioavailability of certain drugs resulting in a decrease in the absorption of atazanavir.</p><p>Risk of loss of efficacy of calcium carbonate when co-administered as phosphate binder with famotidine in hemodialysis patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy:</em></p><p>Famotidine is not recommended for use in pregnancy, and should be prescribed only if clearly needed. Before a decision is made to use famotidine during pregnancy, the physician should weigh the potential benefits from the drug against the possible risks involved.</p><p>To date, no other relevant epidemiological data are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal / foetal development, parturition or postnatal development (see section 5.3).</p><p><em>Breast-feeding:</em></p><p>Famotidine is excreted in breast milk. Breast-feeding mothers should either stop using this drug or stop breast-feeding, since there is a possibility of famotidine affecting the infant&#39;s gastric acid secretion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some patients have experienced adverse reactions such as dizziness and headache while taking famotidine. Patients should be informed that they should avoid driving vehicles or operating machinery or doing activities which require prompt vigilance if they experience these symptoms.</p><p>(see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Famotidine has been demonstrated to be generally well-tolerated.</p><p><em>[Very Common (&gt;1/10) Common (&gt;1/100, &lt;1/10) Uncommon (&gt;1/1000, &lt;1/100) Rare (&gt;1/10,000, &lt;1/1,000) Very rare (&lt;1/10,000) including isolated cases Not known (cannot be estimated from the available data)]</em></p><p><strong>Blood and the lymphatic system disorders</strong></p><p><em>Very rare</em></p><p>Thrombocytopenia</p><p>Leukopenia</p><p>Agranulocytosis</p><p>Pancytopenia</p><p>neutropenia</p><p><strong>Psychiatric disorders</strong></p><p><em>Very rare</em></p><p>Reversible psychic disturbances including Hallucinations</p><p>Disorientation</p><p>Confusion</p><p>Anxiety disorders</p><p>Agitation</p><p>Depression</p><p>Reduced libido</p><p>Insomnia.</p><p><strong>Nervous system disorders</strong></p><p><em>Common</em></p><p>Headache</p><p>Dizziness</p><p>Uncommon: taste disorder</p><p><em>Very rare</em></p><p>Paraesthesia</p><p>Somnolence</p><p>Epileptic seizures, convulsions; grand mal seizures (particularly in patients with impaired renal function);</p><p><strong>Gastrointestinal disorders</strong></p><p><em>Common</em></p><p>Constipation</p><p>Diarrhoea</p><p><em>Uncommon</em></p><p>Nausea</p><p>Vomiting</p><p>Abdominal discomfort or distension</p><p>Flatulence</p><p>Dry mouth</p><p><strong>Hepato-biliary disorders</strong></p><p><em>Rare</em></p><p>Intrahepatic cholestasis (visible sign: jaundice),</p><p><em>Very rare</em></p><p>Hepatitis; cholestatic jaundice, Increase in liver enzyme abnormalities (transaminases, gamma GT, alkaline phosphatase, bilirubin)</p><p><strong>Metabolism and nutrition disorders</strong></p><p><em>Uncommon</em></p><p><em>Loss of appetite (anorexia)</em></p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p><em>Uncommon</em></p><p>Rash</p><p>Pruritus</p><p>Urticaria</p><p><em>Very rare</em></p><p>Alopecia, Stevens Johnson syndrome/toxic epidermal necrolysis sometimes fatal</p><p><strong>Immune system disorders</strong></p><p><em>Very rare</em></p><p>Hypersensitivity reactions (angioneurotic oedema, anaphylaxis, bronchospasm)</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p><em>Very rare</em></p><p>Interstitial pneumonia sometimes fatal</p><p><strong>Muscoskeletal, connective tissue and bone disorders</strong></p><p><em>Very rare</em></p><p>Muscle cramps, Arthralgia</p><p><strong>Cardiac disorders</strong>:</p><p><em>Very rare</em>: AV block with H<sub>2</sub>&nbsp;receptor antagonists administered intravenously</p><p><em>Unknown: </em>Arrhythmia, QT prolongation</p><p><strong>General disorders and administration site conditions:</strong></p><p><em>Uncommon</em>: fatigue</p><p><em>Very rare:</em>&nbsp;chest tightness</p><p><strong>Reproductive system and breast disorders:</strong></p><p>Very rare: impotence</p><p><em>Adverse Effects - Causal Relationship Unknown</em></p><p>Rare cases of gynecomastia, have been reported, however, in controlled clinical trials the incidences were not greater than those seen with placebo.</p><p><strong><u>Please report adverse drug events to: </u></strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse reactions in overdose cases are similar to the adverse reactions encountered in normal clinical experience (see Side Effects).</p><p>No cases of overdose have been reported so far.</p><p>Patients suffering from Zollinger-Ellison syndrome have received daily doses of up to 800 mg over a period of one year without exhibiting any significant undesirable effects.</p><p>In the event of overdose the aim should be to remove any unabsorbed drug from the alimentary tract with the usual measures from the gastrointestinal tract, clinical monitoring, and supportive therapy should be employed.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: A02B A03</p><p>Pharmacotherapeutic group: Histamine H<sub>2</sub>&nbsp;receptor antagonist.</p><p>Famotidine is an effective competitive H<sub>2</sub>&nbsp;receptor antagonist, the effect of which is particularly clearly concentrated on H<sub>2</sub>&nbsp;receptors. It reduces the concentration and amount of acid and pepsin of the gastric juices in the basal and stimulated secretion.</p><p>The effect of oral administration of famotidine is rapid. The effect of famotidine is long lasting when recommended doses are used, and it is effective with relatively low concentrations in the blood. The duration of effect, plasma concentration and secretion in the urine are dose dependent.</p><p>Oral administration of famotidine leads to the antacid effect starting within an hour of administration. The peak effect is dose dependent and it is achieved within 1-3 hours of administration.</p><p>In clinical studies famotidine was found to relieve the pain associated with ulceration, usually during the first week of treatment, and it reduced the gastric acid secretion with one single daily dose at bedtime.</p><p>Individual oral doses of 20mg and 40mg effectively inhibited the basal night-time secretion of gastric acid; mean gastric acid secretion was inhibited over a period of 10 hours by 86% and 94%, respectively. The same doses, administered in the morning, inhibited the gastric acid secretion stimulated by eating for 3-5 hours p.a. by a mean of 76% and 84%, respectively. 8-10 hours after administration, the levels were at 25% and 30%, respectively, although the effect of one 20mg dose persisted for only 6-8 hours in some of the volunteers.</p><p>The basal night-time intragastric pH value was increased to a mean of 5 and 6.4 by evening doses of 20mg and 40mg of famotidine, respectively. When famotidine was administered after breakfast, the pH value in both the 20mg and the 40mg groups was increased to approximately 5 after 3 and 8 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption.</em></p><p>Famotidine is rapidly absorbed. Peak plasma concentration is dose dependent and is achieved within 1-3 hours of administration. The kinetics of famotidine are linear. The bioavailability of oral famotidine is 40-45% on average. Food contained in the stomach will not affect the bioavailability. First pass metabolism of famotidine is minor. Repeat administration will not cause accumulation of the drug in the body.</p><p><em>Distribution.</em></p><p>The binding of famotidine in plasma proteins is relatively small (15-20%). The plasma half-life is about 3 hours both after oral single doses and during repeated administration (5 days).</p><p><em>Biotransformation</em></p><p>Up to 30-35 % of famotidine is metabolised in the liver to an inactive sulfoxide metabolite.</p><p><em>Elimination</em></p><p>When administered orally, an average of 65-70% of the absorbed famotidine is excreted in the urine. About 25-30% of the total oral dose is excreted unchanged in the urine. The renal clearance of famotidine is 250-450 ml/min, so consequently, excretion also takes place through tubular secretion. A small proportion may be secreted as sulfoxide.</p><p><em>Pharmacokinetics in different patient groups.</em>&nbsp;The average elimination half-life of famotidine in plasma was prolonged to 11.7 hours in patients with creatinine clearance of 30ml/min or less. Patients with maximum creatinine clearance of 10 ml/min had an average plasma half-life of approximately 13 hours. The elimination half-life in these patients may exceed 20 hours. In patients with anuria the elimination half-life was prolonged to about 24 hours. In patients with creatinine clearance of 30 ml/min or less, only 21.2% of the intravenous injection was excreted in the urine.</p><p>In men with liver cirrhosis, famotidine plasma concentration and excretion of famotidine in the urine were of the same degree as in healthy trial subjects. Disturbance of liver function apparently has no effect on the pharmacokinetics of famotidine.</p><p>Pharmacokinetic studies on elderly patients showed no signs of any clinically significant age-related changes; however, age-related impairment of renal function should be considered when determining the dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non clinical data on famotidine reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Microcrystalline cellulose, pregelatinized starch, magnesium stearate, talc, hypromellose, titanium dioxide, macrogol, sunset yellow (E110), red carmoisine (E122) and indigo carmine (E132).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Protect from light. Store in a dry place. Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td style="width:224px"><strong>Outer packaging&nbsp;&nbsp;</strong></td><td style="width:184px"><strong>Immediate packaging</strong></td></tr><tr><td style="width:224px"><p>Carton</p><p>Leaflet</p></td><td style="width:184px">Aluminum foil, PVC/PVDC</td></tr></tbody></table><p dir="ltr">Famodar<sup>&reg;</sup> 40 mg film coated tablets are available in packs of 10 (one blister), 400 (40 blisters) and 500 (50 blisters) film coated tablets.</p><p dir="ltr">Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No special requirements for disposal.</p><p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O. Box 9364 
Na’ur - Jordan 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/03/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>